Amlodipine and nifedipine associations with B-type natriuretic peptide in women with hypertension and heart failure with preserved ejection fraction
American Journal of Hypertension · 19.10.2026
DOI: 10.1093/ajh/hpag123 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, online erschienen am 19.10.2026. Verfasst von Eisaku Harada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan. Die Arbeit nennt 29 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Calcium channel blockers (CCBs) are frequently prescribed to manage hypertension in patients with heart failure with preserved ejection fraction (HFpEF). However, whether individual dihydropyridine agents exert uniform class effects on myocardial wall stress remains unclear.
Methods
This retrospective, single-center observational study analyzed 465 consecutive patients with hypertension and HFpEF (354 women and 111 men) evaluated at Kumamoto Kinoh Hospital between May 2012 and July 2018. Multivariable linear regression models assessed associations between individual dihydropyridine CCBs (amlodipine vs nifedipine) and plasma log-transformed B-type natriuretic peptide (lnBNP) levels.
Results
In multiple imputation models among women, adjusted differences in lnBNP relative to no-CCB were 0.236 (95% CI, 0.031 to 0.441) for nifedipine and −0.118 (95% CI, −0.273 to 0.037) for amlodipine. Direct linear contrasts in women confirmed lower lnBNP levels with amlodipine than with nifedipine (adjusted difference, −0.355; 95% CI, −0.562 to −0.147). In men, the corresponding amlodipine-vs-nifedipine difference was −0.051 (95% CI, −0.697 to 0.595; P = .876). The formal sex-by-drug interaction contrast in complete-case analysis yielded an adjusted difference of −0.424 (95% CI, −1.055 to 0.208; P = .188), with male precision constrained by sample size (7 male nifedipine users).
Conclusions
In women with hypertension and heart failure with preserved ejection fraction, amlodipine use was associated with lower adjusted ln(BNP) levels than nifedipine use. These observational findings challenge the assumption of an interchangeable dihydropyridine class effect on myocardial wall stress, suggesting that individual pharmacological profiles—rather than uniform class-level equivalence—warrant attention in clinical evaluations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Kumamoto, Japan.
- Department of Anatomy, Faculty of Life Sciences, Kumamoto University 1-1-1 Honjo, Chuo-ku, Kumamoto City 860-8556, Japan.
Zitieren
APA
Harada, E., Yamada, T., Mizuno, Y., Arima, Y., Muta, M., Kikuta, K., & Yasue, H. (2026). Amlodipine and nifedipine associations with B-type natriuretic peptide in women with hypertension and heart failure with preserved ejection fraction. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpag123
Vancouver
Harada E, Yamada T, Mizuno Y, Arima Y, Muta M, Kikuta K, et al. Amlodipine and nifedipine associations with B-type natriuretic peptide in women with hypertension and heart failure with preserved ejection fraction. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpag123
BibTeX
@article{Harada2026,
author = {Harada, Eisaku and Yamada, Toshihiro and Mizuno, Yuji and Arima, Yuichiro and Muta, Makoto and Kikuta, Koichi and Yasue, Hirofumi},
title = {Amlodipine and nifedipine associations with B-type natriuretic peptide in women with hypertension and heart failure with preserved ejection fraction},
journal = {American Journal of Hypertension},
year = {2026},
doi = {10.1093/ajh/hpag123}
}
EUVIMED